脂质检测的革新:"超越常规"之见OA
Innovation in lipid detection:insights"beyond the routine"
脂质代谢异常与代谢相关脂肪性肝病、心血管疾病、肿瘤等全身性疾病的发生发展密切相关.临床传统脂质检测以总胆固醇(TC)、甘油三酯(TG)等有限指标为核心,难以满足精准医学时代对疾病风险分层、精准诊疗及预后评估的临床需求.文章系统梳理了脂质检测技术从常规定量向高覆盖定量、痕量分析、空间定位及单细胞分辨率的革新历程,重点阐述高覆盖脂质组学、空间脂质组学、单细胞脂质组学等前沿技术的技术优势与研发进展,深入展示革新性脂质检测技术在疾病特异性生物标志物筛选、发病分子机制解析及个体化治疗方案制定等领域的应用价值,旨在为推动脂质检测技术的临床转化与落地应用提供理论参考和实践依据.
Abnormal lipid metabolism is closely associated with the occurrence and progression of systemic diseases including metabolic dysfunction-associated steatotic liver disease,cardiovascular diseases,and tumors.Conventional clinical lipid detection focuses on limited indicators such as total cholesterol(TC)and triglycerides(TG),which are far from meeting the clinical requirements for disease risk stratification,precise diagnosis and treatment,and prognostic evaluation in the era of precision medicine.This paper systematically reviews the innovative evolution of lipid detection technologies from conventional quantification to high-coverage quantification,trace analysis,spatial localization and single-cell resolution.It highlights the technical advantages and research progress of cutting-edge technologies including high-coverage lipidomics,spatial lipidomics,and single-cell lipidomics,and demonstrates in depth the application value of innovative lipid detection technologies in the screening of disease-specific biomarkers,elucidation of pathogenic molecular mechanisms,and formulation of individualized therapeutic regimens.This review is intended to provide theoretical reference and practical basis for promoting the clinical translation and practical application of lipid detection technologies.
王佳煜;税光厚
江苏省代谢性疾病分子靶标与干预重点实验室,常州中科脂典生物技术有限责任公司,江苏常州 213022广州国家实验室,广东 广州 510005
医药卫生
脂质检测脂质组学代谢异常生物标志物精准医学
lipid detectionlipidomicsmetabolic disordersbiomarkersprecision medicine
《中国实用内科杂志》 2026 (8)
649-653,5
国家自然科学基金"糖脂代谢的时空网络调控"集成项目(92357308)及创新群体项目(32321004)
评论